Biocon subsidiary caught offering bribe to waive off trial of new drug
The CBI apprehended Joint Drugs Controller S. Eswara Reddy for allegedly receiving a ₹4-lakh bribe to waive phase-three clinical trial of Insulin Aspart injection, an underdevelopment product of Biocon Biologics, officials said The CBI apprehended Joint Drugs Controller S. Eswara Reddy for allegedly receiving a ₹4-lakh bribe to waive phase-three clinical trial of Insulin Aspart […]
Continue Reading
